24 September 2013
Responding to the NHS England announcement that a new Herceptin injection will mean breast cancer patients can be treated in just two to five minutes compared to the 30-90 minute intravenous infusion, Jacqui Graves, Head of Health and Social Care at Macmillan Cancer Support, says:
'It is hugely encouraging that a new Herceptin injection will be offered to breast cancer patients across the UK. This demonstrates a significant breakthrough in the treatment of cancer.
'We know that cancer treatment can be a gruelling process for many. This injection is a less invasive option and will result in treatment times being dramatically reduced. This means thousands will have the freedom to spend more time doing what they want and less time stuck in hospital beds. Those precious extra hours gained each month will mean that breast cancer patients can comfortably focus on their personal recovery process outside of a clinical environment.
'Macmillan Cancer Support looks forward to seeing this new treatment implemented across the UK.'
For further information, please contact:
Cora Bauer, Media and PR Officer, Macmillan Cancer Support
0207 091 2016 (out of hours 07801 307068)
Notes to Editors:
About Macmillan Cancer Support
More than one in three of us will get cancer. For most of us it will be the toughest fight we ever face. And the feelings of isolation and loneliness that so many people experience make it even harder.
But you don’t have to go through it alone. The Macmillan team is with you every step of the way.
We are the nurses and therapists helping you through treatment. The experts on the end of the phone. The advisers telling you which benefits you’re entitled to. The volunteers giving you a hand with the everyday things. The campaigners improving cancer care. The community there for you online, any time. The supporters who make it all possible.
Together, we are all Macmillan Cancer Support.